ADR News Bulletin 2021 December (Volume 23 Number 3)

Bulletin Highlights:

  • Allopurinol-induced severe cutaneous adverse reactions and the role of HLA-B*5801 genotyping – a reminder
  • Updates on adulterated products reported to HSA
  • WHO-UMC-HSA Inter-Regional Pharmacovigilance Training Workshop 2021
  • AE Case in Focus 1: Test Yourself - What could have caused the chest discomfort in this patient?
  • AE Case in Focus 2: Test Yourself - What could have caused the patient’s cough with haemoptysis?

Click on the link below to download the issue in pdf:

ADR_News_Dec 2021_Vol23_No32136 KB

Healthcare professional, Industry member, Therapeutic Products
Published:

Adverse Drug Reaction News Bulletins

24 Dec 2021
Doctors, dentists and pharmacists can claim continuing education points for reading each issue of the HSA ADR News Bulletin. Doctors can apply for one non-core Continuing Medical Education (CME) point under category 3A, dentists can apply for one Continuing Professional Education (CPE) point under category 3A and pharmacists can apply for one patient-care Continuing Professional Education (CPE) point under category 3A per issue of the bulletin. Each issue of the bulletin is valid for two years.